Official Blog of © The Horse Fund
Hayley and Comet, who feature in many of the Int'l Fund for Horses' campaign flyers, are back. This time the popular cartoon horses star in the March for PMU Horses flyer to Pfizer. Pfizer bought out Wyeth, and now responsible for continuing with the outdated methods in the manufacture of the Premarin family of drugs,… Continue reading Cartoon horses Hayley and Comet back in flyer to Pfizer re Premarin
UPDATE. March 1, 2014. :: See Updated Letter to Pfizer The Int'l Fund for Horses call on pharmaceutical giant Pfizer to find an alternative to the Premarin family of drugs. Premarin, Prempro and the anticipated "new" drug Aprela, manufactured with the estrogen rich urine of pregnant mares, or conjugated equine estrogen. In a letter to… Continue reading Int’l Fund for Horses calls on Pfizer to find alternative to Premarin like drugs
Written by JANE ALLIN Chief Research Analyst Introduction With the merger of Pfizer and Wyeth in 2009 a prelude of optimistic hope to end the suffering of the pregnant mares and their foals of the PMU (Pregnant Mare's Urine) industry quickly sputtered to a stall. In its infancy, it was soon apparent that Pfizer would… Continue reading The PMU Industry: 2010 Year in Review
Written by JANE ALLIN Chief Research Analyst Conventional HRT such as Premarin® and Prempro® is manufactured from conjugated equine estrogens (CEEs) extracted from pregnant mare’s urine. To produce these drugs, the pregnant mares are confined for 6 months connected to a urine collection device which chaffs their flanks and can induce inflammation and severe infections.… Continue reading Pregnant Mares and HRT – The Bad News Keeps on Coming
Written by JANE ALLIN Research Analyst, Int'l Fund for Horses (August 3, 2010) -- The introduction of Aprela® looms ever closer in the EU and Japan. Viviant® (i.e. bazedoxifene), a SERM (selective estrogen receptive modulator) which is the post-menopausal osteoporosis component of Aprela® was approved by the European Commission under the name Conbriza in April… Continue reading A Disturbing Trend in Pfizer’s Agenda
Written by JANE ALLIN Research Analyst, Int'l Fund for Horses The scandalous ghost writing of scientific papers subsidized by Wyeth (now a division of Pfizer) has re-surfaced in the news once again. In July of 2009, a U.S. District Court Judge granted the motion to make discovery materials that were part of an on-going lawsuit… Continue reading Busted: Wyeth Used Ghostwriters To Place Over 40 “Scientific” Articles In Medical Journals
Written by JANE ALLIN Research Analyst | Int'l Fund for Horses Page 1 A recent report by Agriculture Canada gives tenuous optimism for the stopping of suffering of the mares and foals at the mercy of the pregnant mare's urine (PMU) industry. Giant drug manufacturer Wyeth, a division of Pfizer, has announced they intend to… Continue reading The Rise and Fall of the PMU Industry
Written by JANE ALLIN Research Analyst Pfizer, the world’s largest drug maker, has announced the withdrawal of its new drug application (NDA) for Fablyn® a selective estrogen receptor modulator (“SERM”) for the treatment of both osteoporosis and selected consequences of menopause. As with other SERMs, Fablyn® has been shown to have significant side-effects which contraindicate… Continue reading Pfizer to Withdraw Fablyn NDAs
Written by JANE ALLIN Research Analyst | Int'l Fund for Horses Despite the tainted history of Premarin® and its acknowledged contribution to a plethora of cancers and other maladies in women who trustingly relied upon it for the relief of menopausal symptoms, Wyeth, and now Pfizer, shamelessly continue to promote the use of conjugated equine… Continue reading Premarin Mares and Foals: Aprela, the Lesser Evil?
Written by VIVIAN GRANT NATASHA SINGER and DUFF WILSON have written a well-researched, well-documented and important article on Wyeth and its Premarin® family of drugs for the New York Times, December 12, 2009. It is critical reading for women and horse advocates, as these drugs are potentially lethal to both women and horses. Here is… Continue reading Menopause, as brought to you by Big Pharma
Tuesday's Horse 